Do You Need a Pacemaker After Ablation?

Most people who undergo catheter ablation for atrial fibrillation do not need a pacemaker afterward. Across large studies, roughly 2 to 6 percent of patients end up with one, and the number depends heavily on the type of ablation, the underlying heart condition, and whether the heart’s natural pacemaker was already struggling before the procedure. The exception is a deliberate strategy called “ablate and pace,” in which the plan from the start is to destroy the heart’s electrical junction and implant a pacemaker to take over. Understanding the difference between these scenarios, and the risk factors that push someone toward needing a device, matters for anyone facing an ablation.

Why Ablation Type Changes Everything

The word “ablation” covers several very different procedures, and the chance of needing a pacemaker afterward varies enormously depending on which one you have. Catheter ablation for atrial fibrillation, where a cardiologist threads a catheter into the heart and isolates the pulmonary veins, carries the lowest pacemaker risk. One large study tracking patients over an average of about two and a half years found that 5.6 percent eventually received a pacemaker.¹ Interestingly, that rate was not meaningfully different from patients who had electrical cardioversion instead, suggesting the ablation itself may not always be the direct cause; some patients were heading toward a pacemaker regardless.

Surgical ablation is a different story. The Cox-Maze IV procedure, which creates a pattern of scar lines across the atria during open-heart surgery, carries a substantially higher pacemaker rate. A nationwide registry study found that about 13 percent of Cox-Maze patients needed a pacemaker within the first 30 days, and the cumulative rate climbed to roughly 27 percent by eight years.² A modified cryo-Maze approach showed a somewhat lower but still meaningful rate, with about 8 percent needing a late pacemaker over a median follow-up of four and a half years.³ In these surgical cases, the most common reason for pacemaker implantation was sick sinus syndrome, followed by complete heart block.⁴

Then there is AV node ablation, which is intentionally permanent. In this approach, the electrical bridge between the upper and lower chambers of the heart is deliberately destroyed. The heart cannot conduct its own rhythm afterward, so a pacemaker is always implanted beforehand or during the same session. The American College of Cardiology describes this as a reasonable second-line strategy for patients whose atrial fibrillation has resisted other treatments, with the understanding that the patient will be pacemaker-dependent for life.⁵

Who Is Most at Risk After Catheter Ablation

If you are having a standard catheter ablation for atrial fibrillation, the overall pacemaker risk is low, but certain factors push it higher. A study of patients undergoing ablation for persistent atrial fibrillation identified three strong predictors: older age, a history of sinus pauses before the procedure, and atria with low-voltage areas (a marker of more advanced scarring).⁶ Pre-existing sinus pauses were the strongest single predictor, raising the odds roughly eightfold.

Broader population data confirm that older age, female sex, higher burden of comorbidities like heart failure or coronary artery disease, and pre-existing conduction disorders all increase the risk of eventually needing a pacemaker after AF ablation.¹ In the surgical ablation world, longer duration of atrial fibrillation before the operation and having multiple valve procedures done at the same time also raise the risk.³

When Ablation Unmasks a Hidden Problem

One of the more unsettling scenarios involves patients whose sinus node, the heart’s natural pacemaker, was quietly failing before ablation but whose symptoms were hidden by the atrial fibrillation itself. In a pattern sometimes called tachy-brady syndrome, the fast atrial fibrillation episodes mask the fact that the sinus node cannot maintain a normal rate when the arrhythmia stops. Roughly three percent of patients with persistent atrial fibrillation have a concealed sinus node disease that only becomes apparent once the ablation restores normal rhythm.⁷

A study focused specifically on patients with known underlying sinus node dysfunction who underwent AF ablation found a pacemaker implantation rate of about 11 percent over roughly four years of follow-up, with more than half of those pacemakers placed within the first three months.⁸ That early clustering suggests these patients had pre-existing disease that was exposed, not new damage caused by the ablation.

A case series documented a more dramatic version: six patients with no previous symptoms of sinus node disease developed long pauses and fainting episodes within hours to two months after pulmonary vein isolation, and five of them needed urgent pacemaker implantation.⁹ These cases are uncommon, but they are a reminder that ablation can reveal problems the patient never knew they had.

Transient Heart Block and the Waiting Game

Not every conduction disturbance after ablation is permanent. One of the more nerve-wracking moments in a post-ablation recovery is when a patient develops heart block on the monitor. The catheter can bruise or irritate the tissue near the heart’s conduction system without permanently destroying it. Swelling around the AV node after radiofrequency energy or cryotherapy often causes temporary slowing or blocking of electrical signals. Once the swelling resolves, normal conduction typically returns.¹⁰

A case report illustrated this well: a patient developed complete heart block during a catheter ablation for an accessory pathway. It initially appeared to be a permanent injury requiring a pacemaker, but closer analysis showed the block was caused by the catheter physically bumping the AV node during the transseptal puncture, not by the ablation energy itself. With conservative management, conduction recovered fully.¹¹ This is one reason many electrophysiologists prefer to wait and observe rather than rush to implant a pacemaker when heart block appears immediately after a procedure. The challenge is distinguishing true injury from temporary inflammation, and that judgment call often requires days of monitoring.

Anatomy and Why Location Matters

The heart’s conduction system runs through a compact area, and certain ablation targets sit uncomfortably close to it. The triangle of Koch, a small anatomical region on the right atrial side, contains the AV node and its extensions. Any ablation performed near this area carries some risk of damaging the conduction system and creating heart block that requires a pacemaker.¹²

This anatomical risk is particularly relevant in certain types of ablation. Midseptal ablation sites, which sit right next to the AV node, carry the highest risk of inadvertent heart block. A large pediatric registry found that AV block occurred in about 10 percent of midseptal ablations, compared to roughly 1 percent for right posteroseptal sites.¹³ The operator’s experience was the only significant risk factor for inadvertent AV block in that registry, meaning that less experienced operators were more likely to cause the complication. For patients, this translates into a simple practical message: the procedure volume and experience of the center matters.

Variability in the anatomy of this region from patient to patient adds another layer of complexity. The compact AV node does not sit in precisely the same spot in every heart, and in patients with congenital heart disease like Ebstein’s anomaly, the anatomy can be significantly distorted.¹⁴

Does the Ablation Technology Matter

Pulsed field ablation, a newer technology that uses short electrical pulses rather than heat or cold, has generated considerable interest partly because of its potential to be gentler on non-cardiac tissue. A systematic review and meta-analysis comparing pulsed field ablation with thermal ablation (radiofrequency and cryo) found that heart rate variability, a marker of the autonomic nervous system’s health, was better preserved after pulsed field ablation. Resting heart rate rose less, and the overall autonomic profile was less disrupted.¹⁵ The overall rate of bradyarrhythmias requiring a pacemaker, however, did not differ significantly between the two technologies. Transient slowing during the procedure itself was actually more common with pulsed field ablation, but it tended to resolve. The bottom line is that pulsed field ablation may spare the autonomic nervous system some collateral damage, but it has not been shown to reduce the need for permanent pacemakers.

The Deliberate “Ablate and Pace” Strategy

For patients whose atrial fibrillation cannot be controlled by drugs or standard ablation, deliberately destroying the AV junction and implanting a permanent pacemaker can be a highly effective last resort. This is fundamentally different from the scenarios above: the pacemaker is not a complication, it is the treatment plan. Early research showed that this approach roughly doubled quality-of-life scores, significantly reduced hospital admissions and doctor visits, and cut episodes of heart failure.¹⁶

More recent data from the APAF-CRT trial found that when this strategy is combined with cardiac resynchronization therapy, the outcomes go beyond symptom relief. Heart failure-related hospitalization and death occurred in 30 percent of the ablate-and-pace group compared to 45 percent of patients treated with medications alone, along with better symptom and physical limitation scores.¹⁷ A separate observational study found that quality of life improved in about two-thirds of patients who underwent AV node ablation and pacing, and remained stable in another 12 percent.¹⁸

Implanting the pacemaker and performing the AV junction ablation in a single session is well-established and appears safe. An early study specifically tested whether the radiofrequency energy used during ablation could interfere with a freshly implanted pacemaker. It did not: no malfunctions, no sensing problems, no changes in pacing thresholds were observed either acutely or during long-term follow-up.¹⁹ Leadless pacemakers, which are tiny devices implanted directly inside the heart without wires, have also been successfully combined with AV junction ablation. A study using the Micra leadless pacemaker found no device dislodgement, malfunction, or significant threshold changes over 12 months of follow-up.²⁰

How Modern Pacing Approaches Are Changing Outcomes

If you do end up needing a pacemaker after ablation, the type of pacing lead used makes a meaningful difference. Conduction system pacing, which aims to activate the heart through its own natural wiring rather than just stimulating the muscle directly, has become a preferred approach for patients undergoing AV node ablation. There are two main flavors: His-bundle pacing and left bundle branch area pacing.

Head-to-head studies consistently show that left bundle branch area pacing has practical advantages. In a prospective comparison, the pacemaker and ablation procedures were quicker, complete AV block was achieved more reliably (about 92 percent vs. 79 percent), and the one-year composite outcome was better in the left bundle branch pacing group.²¹ A separate study confirmed the pattern: His-bundle pacing leads were more likely to develop rising thresholds over time (about 48 percent exceeded a concerning level), and some had to be deactivated entirely. Redo AV junction ablation procedures were needed in 14 percent of the His-bundle group but none in the left bundle branch group.²² Both approaches preserved or improved the heart’s pumping function, and patients with reduced pump function at baseline saw significant improvement.

Anticoagulation During Combined Procedures

Patients undergoing both device implantation and ablation often take blood thinners, and there has been understandable concern about bleeding risk at the pacemaker pocket site when anticoagulation is continued through the procedure. Evidence suggests the risk is manageable either way. A study comparing patients who continued their blood thinners with those who paused them found that clinically significant bleeding at the pacemaker site occurred in about 2 percent of patients in both groups, with no meaningful difference between the two strategies.²³ This means the decision to continue or interrupt blood thinners around device implantation can be tailored to the individual patient’s stroke risk rather than driven by fear of pocket bleeding.

Pediatric and Congenital Heart Patients

The pacemaker conversation carries extra weight for younger patients and those with congenital heart disease, because a pacemaker implanted early means decades of device dependency, lead replacements, and potential complications. In the pediatric radiofrequency ablation registry, inadvertent AV block occurred in about 1.2 percent of all ablation procedures, with about 60 percent of those cases being permanent third-degree block requiring a pacemaker.¹³ The ablation site mattered enormously: midseptal locations had the highest risk, and operator experience was the only significant modifiable factor. For families weighing the decision, the complication rate has likely improved since the early 1990s data from that registry, but the fundamental anatomical vulnerability remains the same. Centers with high procedure volumes in pediatric electrophysiology remain the safest option for children facing these procedures.